Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Ozanimod Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 257,511Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Zeposia

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Zeposia

    Ozanimod Hydrochloride

    arrow
    AIChE Annual Meeting
    Not Confirmed

    Brand Name : Zeposia

    U.S.A
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Bristol Myers Squibb

    Ozanimod Hydrochloride

    Main Therapeutic Indication : Neurology

    Currency : USD

    2020 Revenue in Millions : 12

    2019 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Zeposia

    Ozanimod Hydrochloride

    arrow
    AIChE Annual Meeting
    Not Confirmed

    Brand Name : Zeposia

    U.S.A
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Bristol Myers Squibb

    Ozanimod Hydrochloride

    Main Therapeutic Indication : Neurology

    Currency : USD

    2021 Revenue in Millions : 134

    2020 Revenue in Millions : 12

    Growth (%) : 1,017

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Zeposia

    Ozanimod Hydrochloride

    arrow
    AIChE Annual Meeting
    Not Confirmed

    Brand Name : Zeposia

    U.S.A
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Bristol Myers Squibb

    Ozanimod Hydrochloride

    Main Therapeutic Indication : Neurology

    Currency : USD

    2022 Revenue in Millions : 250

    2021 Revenue in Millions : 134

    Growth (%) : 87

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Zeposia

    Ozanimod Hydrochloride

    arrow
    AIChE Annual Meeting
    Not Confirmed

    Brand Name : Zeposia

    U.S.A
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Bristol Myers Squibb

    Ozanimod Hydrochloride

    Main Therapeutic Indication : Neurology

    Currency : USD

    2023 Revenue in Millions : 434

    2022 Revenue in Millions : 250

    Growth (%) : 74

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Zeposia

    Ozanimod Hydrochloride

    arrow
    AIChE Annual Meeting
    Not Confirmed

    Brand Name : Zeposia

    U.S.A
    arrow
    AIChE Annual Meeting
    Not Confirmed

    Bristol Myers Squibb

    Ozanimod Hydrochloride

    Main Therapeutic Indication : Neurology

    Currency : USD

    2024 Revenue in Millions : 566

    2023 Revenue in Millions : 434

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF